Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma

Liver transplantation (LT) is regarded as the best option for radical treatment in patients with very early (stage 0) or early (stage A) hepatocellular carcinoma (HCC), according to the Barcelona Clinic Liver Cancer guideline.[1 –3] Careful patient selection is important in reducing the tumor recurrence rate and maximizing the effectiveness of LT for HCC because the availability of deceased and living donor organs is limited. Thus, the Milan criteria are used as the gold standard to increase the post-transplant survival r ate of patients with HCC, with a 5-year survival rate of 70% after LT and a recurrence rate of less than 20%.

Source: Journal of Hepatology - February 2, 2018 Category: Gastroenterology Authors: Ah Yeong Kim, Dong Hyun Sinn, Woo Kyoung Jeong, Young Kon Kim, Tae Wook Kang, Sang Yun Ha, Chul Keun Park, Gyu Seong Choi, Jong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, Min-Ji Kim, Insuk Sohn, Sin-Ho Jung, Seung Woon Paik, Won Jae Lee Source Type: research